118 related articles for article (PubMed ID: 22480117)
1. Postherapeutic follow-up of colorectal cancer patients treated with curative intent.
Mazilu L; Ciufu N; Gălan M; Suceveanu AI; Suceveanu AP; Parepa IR; Tofolean D
Chirurgia (Bucur); 2012; 107(1):55-8. PubMed ID: 22480117
[TBL] [Abstract][Full Text] [Related]
2. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
[TBL] [Abstract][Full Text] [Related]
3. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
[TBL] [Abstract][Full Text] [Related]
4. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
[TBL] [Abstract][Full Text] [Related]
5. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
8. Yield of routine imaging after curative colorectal cancer treatment.
Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
[TBL] [Abstract][Full Text] [Related]
9. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.
McCall JL; Black RB; Rich CA; Harvey JR; Baker RA; Watts JM; Toouli J
Dis Colon Rectum; 1994 Sep; 37(9):875-81. PubMed ID: 8076486
[TBL] [Abstract][Full Text] [Related]
10. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
[TBL] [Abstract][Full Text] [Related]
11. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
12. Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer.
Kanellos I; Zacharakis E; Demetriades H; Christoforidis E; Kanellos D; Pramateftakis MG; Betsis D
Surg Today; 2006; 36(10):879-84. PubMed ID: 16998681
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
Uratani R; Toiyama Y; Shimura T; Mori K; Fujikawa H; Hiro J; Ohi M; Inoue Y; Tanaka K; Araki T; Mohri Y; Kusunoki M
Anticancer Res; 2015 Oct; 35(10):5639-48. PubMed ID: 26408737
[TBL] [Abstract][Full Text] [Related]
14. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
15. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
16. Results of long-term follow-up after curative resection of Dukes A colorectal cancer.
Wichmann MW; Müller C; Hornung HM; Lau-Werner U; Schildberg FW;
World J Surg; 2002 Jun; 26(6):732-6. PubMed ID: 12053228
[TBL] [Abstract][Full Text] [Related]
17. Modified Glasgow Prognostic Score and Carcinoembryonic Antigen Predict Poor Prognosis in Elderly Patients with Colorectal Cancer.
Numata K; Ono Y; Toda S; Kamioka Y; Suematsu H; Sawazaki S; Tsuchida K; Higuchi A; Saeki H; Rino Y; Masuda M; Matsukawa H
Oncol Res Treat; 2020; 43(4):125-133. PubMed ID: 32040953
[TBL] [Abstract][Full Text] [Related]
18. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
[TBL] [Abstract][Full Text] [Related]
19. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
[TBL] [Abstract][Full Text] [Related]
20. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]